| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |